HLA-DR Antikörper (FITC)
(1 reference)-
- Target Alle HLA-DR Produkte
- HLA-DR
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DR Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS)
- Spezifität
- The antibody MEM-12 recognizes a common extracellular epitope on human HLA-DR which is dependent on the association of alpha and beta chains. DR is the isotype of human MHC Class II molecules expressed on antigen-presenting cells (APC, dendritic cells, B lymphocytes, monocytes, macrophages).
- Kreuzreaktivität (Details)
- Human
- Aufreinigung
- Purified antibody is conjugated with fluorescein isothiocyanate (FITC) under optimum conditions and unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
- Immunogen
- thymocyte membrane
- Klon
- MEM-12
- Isotyp
- IgG1
-
anti-HLA-DR (HLA-DR) antibody
HLA-DR Reaktivität: Human FACS, WB, IHC, ISt, StM Wirt: Maus Monoclonal TAL 1B5 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IP Wirt: Maus Monoclonal MEM-12 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC Wirt: Maus Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS Wirt: Maus Monoclonal L243 PE
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IHC, IF, ISt, StM Wirt: Maus Monoclonal SPM289 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, IP Wirt: Maus Monoclonal HL-39 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC, Func Wirt: Maus Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 PE
anti-HLA-DR (HLA-DR) antibody (APC)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 APC
anti-HLA-DR (HLA-DR) antibody (PerCP)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 PerCP
-
- Applikationshinweise
- Flow cytometry: The reagent is designed for analysis of human blood cells using 20 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.
- Kommentare
-
The purified antibody is conjugated with Fluorescein isothiocyanate (FITC) under optimum conditions. The reagent is free of unconjugated FITC and adjusted for direct use. No reconstitution is necessary.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Rekonstitution
- No reconstitution is necessary.
- Buffer
- Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
-
Do not freeze.
Avoid prolonged exposure to light. - Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
-
-
: "Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens." in: Tissue antigens, Vol. 28, Issue 5, pp. 288-97, (1987) (PubMed).
-
: "Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens." in: Tissue antigens, Vol. 28, Issue 5, pp. 288-97, (1987) (PubMed).
-
- Target
- HLA-DR
- Andere Bezeichnung
- HLA-DR (HLA-DR Produkte)
- Hintergrund
- HLA-DR, a member of MHC class II glycoproteins, that bind intracellularly processed peptides and present them to the Th cells, is composed of 36 kDa alpha chain and 27 kDa beta chain, both anchored in the plasma membrane. Together with other MHC II molecules HLA-DR plays a central role in the immune system.
- Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
